Australia's largest stock trading and investment forum Australia's #1 stock forum

Never ending story, page-2

First 2 Last

Share
Profile

Follow
Qanoninsanity

7,097 Posts.

3

06/10/21

12:02

Post #: 56600251
Share

Originally posted by kinggtutt: ↑

la la la la la la la la la la

A new vaccine “tailored” to target probable future mutations of the Covid-19 coronavirus will likely be needed by the middle of 2022, according to the head of BioNTech, the biotechnology company that developed the Pfizer shot.The German firm’s CEO, Uğur Şahin, told the Financial Times that Covid-19 variants such as the Delta strain were more contagious but could be tackled by booster shots of current vaccines.However, he added that mutations would emerge that could slip past the body’s vaccine-acquired immune defenses.“This year, [a different vaccine] is completely unneeded. But by mid next year, it could be a different situation,” Sahin said, adding that “tailored” versions of current vaccines would be needed to specifically target the new strains that emerge.

Vaccines for the vaccine , and boosters for the booster.
I'm developing a new line of designer syringes .

Expand

thats so last year Tutty...they'll have a vax patch soon, or a spray. Should have happened years ago. Vax rates would be at over 90% by now if that big sharp needle wasn't involved.
1 Upvote

Reply

Top Stories

Listen: HotCopper Wire Podcast 016 – FY25 ended up not so bad... but Trump unpause is coming

AII

Inside the depths of Panasqueira: A legacy carved in rock

AL3

AML3D hits four-year high on boosted relationship with US Navy

Trump chides Powell as Goldman call for calm. The RBA must be nervous

GYG

Guzman Gomez loses steam as YTD returns -30%; short sellers back

First 2 Last

SPONSORED BY